Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Clinical Trials

As part of Us TOO’s continued commitment to bring news of new interventions and treatments for the benefit of prostate cancer patients, we are pleased to share the following opportunities for participation in clinical trials
Highlighted Prostate Cancer Trials and Studies

The approved treatments for prostate cancer available today were made possible because patients participated in clinical trials. Through clinical trials, doctors find new and better ways to prevent, detect, diagnose, control, and treat illnesses.

However, finding an appropriate clinical trial can be challenging. We encourage you to simplify the process with The Us TOO Prostate Cancer Clinical Trial Finder, a free and confidential service that provides an efficient, user-friendly, customized approach to identify clinical trials relevant for each individual prostate cancer patient.

Responses to a 10-minute questionnaire generate a list of clinical trials within patient specifications that can include treatment preference, geographic area, medication type or brand name, and clinical trial phase (I, II or III). The patient questionnaire can be completed online or on the phone speaking with friendly, knowledgeable clinical trial navigators who speak English and Spanish.

CLICK HERE to visit The Us TOO Prostate Cancer Clinical Trial Finder.

  • Your privacy is important to us; we do not share or sell your information.
  • This search service for clinical trials is comprehensive and inclusive of every clinical trial that can be found on any clinical trial portal, hospital website, or the www.clinicaltrials.gov website (although additional websites providing clinical trial information continue to be listed below on this web page).
  • By participating in a trial, patients have access to the most cutting-edge treatment; there are trials that are recruiting patients at almost every stage.
  • Family members are welcome to search on behalf of their loved ones.
  • Patients are never obligated to enroll or stay in a trial.
  • Starting to search for trials doesn’t mean you must participate.
  • At any point in your disease management journey, you are encouraged to connect with an Us TOO Prostate Cancer Clinical Trial navigator to benefit from the personalized attention and helpful information provided by a caring and informed professional.
  • Upon being diagnosed, patients should be informed about trials specific to their situation. Even if a trial isn’t right for them at the moment, they need to be informed and empowered from the beginning.
  • Contrary to the negative perception held by some people without all of the facts, those who participate in clinical trials are not “guinea pigs” and clinical trials are not a “last resort.”

What is a clinical trial?

A clinical trial is a scientific study to determine how a new medicine or treatment works in people. Through clinical trials, doctors find new and better ways to prevent, detect, diagnose, control, and treat illnesses. Check out a guide from Sanofi on clinical studies: why they matter, how they work, what to expect, and myths and facts.

How is the safety of the participant protected?

The ethical and legal codes that govern medical practice also apply to clinical trials. In addition, most clinical research is federally regulated with built-in safeguards to protect the participants. The trial follows a carefully controlled protocol – a study plan that details what researchers will do. As a clinical trial progresses, researchers report the results of the trial at scientific meetings, in medical journals, and to various government agencies. Individual participants' names are kept confidential and are never mentioned in reports.

What is informed consent?

Informed consent is the process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. If the participant's native language is not English, translation assistance can be provided. The research team provides an informed consent document that includes details about the study, such as its purpose, duration, required procedures, and key contacts. Risks and potential benefits are also explained in the informed consent document. The participant then decides whether or not to sign the document. Informed consent is not a contract, and the participant may withdraw from the trial at any time.

What are the phases of clinical trials?

Phase I Trial:

A Phase I trial evaluates how a new drug should be taken into the body (by mouth, injected into the blood, injected into the muscle, etc.) how often, and a dosage that is safe. In particular, these studies are looking for the highest dose that can safely be given with the fewest serious side effects (maximum tolerated dose). In addition, a Phase I trial might evaluate a new combination of two drugs. In these trials, the effect of one or both of the drugs might be well known but doctors have never before studied the effect of the two drugs together. In these combination studies, doctors watch closely for potential interactions and new side effects when the two drugs are given together. Patients in a Phase I trial will receive the investigational treatment.

Phase II Trial:

A Phase II trial continues to test the safety of the drug, and begins to evaluate how well the new drug works. Phase II studies usually focus on a particular aspect of a disease. In most Phase II trials, they do not test the difference between two therapies, so the participants will almost always get the experimental treatment.

Phase III Trial:

A Phase III trial tests a new drug, a new combination of drugs, or a new surgical procedure in comparison to the current standard for treatment. A participant will usually be assigned to the standard treatment group or the new treatment group at random (called randomization). In Phase III trials, patients rarely receive a placebo. Placebos are typically only given when there is no standard therapy for the disease. People who participate in Phase III clinical trials will either receive the best available standard therapy or the experimental therapy, with an equal chance of receiving either treatment.

What is a placebo?

A placebo is an inactive pill, liquid, or powder that has no treatment value. In clinical trials, experimental treatments are often compared with placebos to assess the experimental treatment's effectiveness. The participants who receive a placebo instead of an active drug or experimental treatment are placed into a control group. Participants who are randomly assigned to the control group are monitored to the same extent as patients receiving the experimental treatment.

When is the best time to search for clinical trials?

The best time to search for clinical trials is when you review your treatment options.

Who sponsors clinical trials?

Clinical trials are sponsored or funded by a variety of organizations or individuals such as physicians, medical institutions, foundations, voluntary groups, and pharmaceutical companies. In addition, federal agencies such as the National Institutes of Health (NIH) sponsor clinical trials. Trials can take place in a variety of locations, such as hospitals, universities, doctors' offices, or community clinics.

Does a participant continue to work with a primary health care provider while in a trial?

Yes. Most clinical trials provide short-term treatments related to a designated illness or condition, but do not provide extended or complete primary health care. In addition, by having the primary health care provider coordinate with the research team, the participant can ensure that other medications or treatments will not conflict with the protocol.

Who is responsible for the costs of care for people taking part in a clinical trial?

The costs of care for people participating in a clinical trial fall into two general categories: 1) routine care costs and 2) research costs. Routine care costs are costs associated with treating a person’s diagnosis whether or not they are in a trial. These costs are usually covered by health insurance, but requirements vary by state and type of health plan. Research costs are costs associated with conducting a clinical trial; these costs may include the costs of extra doctor visits, extra tests, and procedures that are required for the trial but would not be part of routine care. Research costs are usually covered by the organization that sponsors the trial. Many states require that insurance companies cover the costs of routine care for people taking part in a clinical trial. In other states, voluntary agreements between the states and insurance companies include such a provision. However, coverage varies by state, by health insurance plan, and by type of clinical trial.

CLICK HERE to learn more about getting treatment through a clinical trial.

The following are additional websites that provide information on prostate cancer clinical trials. Clinical trials provided by the various resources listed can also be found through The Us TOO Prostate Cancer Clinical Trial Finder.

Highlighted Prostate Cancer Trials and Studies


National Databases

CancerTrials – NCI resource for cancer clinical trials information

Cancer Trials Support Unit (CTSU)
An NCI funded program to facilitate participation (by both patients and physicians) in phase III NCI sponsored trials

Universities and Hospitals

Dana-Farber Cancer Center / Mass General Hospital

University of California San Francisco

University of Michigan Comprehensive Cancer Center Prostate Cancer Trials

University of Texas MD Anderson Cancer Center

Memorial Sloan-Kettering Cancer Center 

Columbia-Presbyterian Medical Center, Herbert Irving Comprehensive Cancer Center